AR010955A1 - Ureas n,n'-sustituidas y el empleo de las mismas como medicamento. - Google Patents

Ureas n,n'-sustituidas y el empleo de las mismas como medicamento.

Info

Publication number
AR010955A1
AR010955A1 ARP980105554A AR010955A1 AR 010955 A1 AR010955 A1 AR 010955A1 AR P980105554 A ARP980105554 A AR P980105554A AR 010955 A1 AR010955 A1 AR 010955A1
Authority
AR
Argentina
Prior art keywords
group
belonging
substituted
substances
ureas
Prior art date
Application number
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR010955A1 publication Critical patent/AR010955A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El invento se refiere a una urea N,N-sustituida empleada en calidad de ingrediente terapéutico activo y que pertenece al grupo de sustancias de formula(1) en donde A representa un grupo de alcanodiilo, preferentemente el grupo metileno, O, CO,S, SO, SO2 y NH, X representa alquilo, cicloalquilo, aralquilo,Y representa alquilo, átomos de halogeno o hidrogeno. Las enfermedades que se indican a continuacion pueden ser tratadas con una urea N,N-sustituidaperteneciente al grupo de las sustancias del invento: (i) alergias; (ii) transplantes; (iii) leucemia y tumores solidos y expresivos de receptor de IL-4;(iv) enfermedades parasitarias; (v) lepra; (vi) las infecciones por hongos; (vii) infecciones por HIV; (viii) inflamacionesy (ix) esclerodermia.
ARP980105554 1997-11-05 1998-11-04 Ureas n,n'-sustituidas y el empleo de las mismas como medicamento. AR010955A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997149979 DE19749979C2 (de) 1997-11-05 1997-11-05 Arzneimittel, enthaltend N,N'-substituierte Harnstoffe und deren Derivate

Publications (1)

Publication Number Publication Date
AR010955A1 true AR010955A1 (es) 2000-07-12

Family

ID=7848395

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105554 AR010955A1 (es) 1997-11-05 1998-11-04 Ureas n,n'-sustituidas y el empleo de las mismas como medicamento.

Country Status (4)

Country Link
AR (1) AR010955A1 (es)
DE (1) DE19749979C2 (es)
PE (1) PE128899A1 (es)
ZA (1) ZA9810080B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469753B1 (en) 1996-05-03 2002-10-22 Starsight Telecast, Inc. Information system
US6376524B1 (en) * 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
EP3109233A1 (en) * 2015-06-22 2016-12-28 The Procter and Gamble Company Urea gellants

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2155856A1 (en) * 1971-10-11 1973-05-25 Leurquin Lab N-2 pyridylureas - with antiinflammatory and analgesic activity
GB1378481A (en) * 1971-12-06 1974-12-27 Quimco Gmbh Preparation of substituted ureas
BE792312A (fr) * 1971-12-06 1973-03-30 Quimco Gmbh Procede de preparation et de purification de thiocarbamates d'ammonium secondaire, disubstitues sur l'atome carbamique d'azote
US4940811A (en) * 1986-12-09 1990-07-10 Ciba-Geigy Corporation N,N-disubstituted ureas and processes for their manufacture
JP2764724B2 (ja) * 1988-04-08 1998-06-11 協同油脂 株式会社 高温で長寿命を有するグリース組成物
AT396363B (de) * 1991-01-18 1993-08-25 Chemie Linz Gmbh Verfahren zur herstellung n-mono- oder n,n-disubstituierter harnstoffe
JP2912713B2 (ja) * 1991-01-30 1999-06-28 エヌティエヌ株式会社 高温耐久性グリース組成物
DE4127562A1 (de) * 1991-08-21 1993-02-25 Chemie Linz Deutschland Verfahren zur herstellung n-mono- oder n,n-disubstituierter harnstoffe
JP3519417B2 (ja) * 1991-10-04 2004-04-12 協同油脂株式会社 高温・高速・高荷重印加用の低起動トルク性に優れる軸受用グリース組成物
JP3150787B2 (ja) * 1992-09-07 2001-03-26 株式会社日本礦油 回転機軸受用グリース組成物
JPH06240058A (ja) * 1993-02-17 1994-08-30 New Japan Chem Co Ltd ポリオレフィン用結晶核剤及びポリオレフィン系樹脂組成物
JPH07164756A (ja) * 1993-12-15 1995-06-27 Nippon Paper Ind Co Ltd 感熱記録体
WO1995033458A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds

Also Published As

Publication number Publication date
PE128899A1 (es) 2000-01-22
DE19749979A1 (de) 1999-05-06
ZA9810080B (en) 1999-04-05
DE19749979C2 (de) 2000-01-13

Similar Documents

Publication Publication Date Title
TR200100917T2 (tr) Aril ve heteroaril sübstitüentli heteroksiklik üreler kullanılarak RAF kinazın inhibe edilmesi
ES2179071T3 (es) Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
ATE249219T1 (de) Antivirale verbindungen
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
SE8505112D0 (sv) Novel pharmacological compounds
BR0215157A (pt) Cis-2,4,5-trifenil-imidazolinas e seu uso no tratamento de tumores
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
SE0102438D0 (sv) New compounds
DE3683823D1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
TR200100439T2 (tr) 1H-İmidazopiridin türevleri
DE69010139T2 (de) Haarkräftigungsmittel.
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
GEP20084284B (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
AR029185A1 (es) Derivado de naftiridina
ATE250622T1 (de) 4'-c-ethynyl-pyrimidine nukleoside
NO20020282L (no) Nytt difenyl-piperidinderivat
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
SE8404065D0 (sv) Novel biologically active compounds
FI970469A (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
ES2066979T3 (es) Derivados de fenoxialquilamina e insecticidas, acaricidas y fungicidas.
AR010955A1 (es) Ureas n,n'-sustituidas y el empleo de las mismas como medicamento.
IT1216104B (it) Peptidi ad attivita' farmaceutica.
PT896822E (pt) 4-aminopirrolo (3,2-d)pirimidinas como antagonistas do receptor de neuropeptideo y

Legal Events

Date Code Title Description
FA Abandonment or withdrawal